Utilization Management
Prior Authorization and Step Therapy Policies for Commercial and Individual Family Business (IFB)
Certain drugs within policies may not be applicable to the specific formulary and plan design. Please refer to the formulary drug list and/or member plan documents to determine coverage status.
| Cholbam PA Policy | Policy |
| Chorionic Gonadotropins PSM Policy | Policy |
| Cinacalcet (Sensipar) PA Policy | Policy |
| Colony Stimulating Factors - Filgrastim Products PA Policy | Policy |
| Colony Stimulating Factors - Filgrastim Products PSM for Basic Formulary | Policy |
| Colony Stimulating Factors - Filgrastim Products PSM for Flex, High Performance, and National Preferred Formularies | Policy |
| Colony Stimulating Factors - Filgrastim Products PSM Policy for High Performance and National Preferred Formularies | Policy |
| Colony Stimulating Factors - Leukine PA Policy | Policy |
| Colony Stimulating Factors - Pegfilgrastim Products and Rolvedon PSM for High Performance and National Preferred Formularies | Policy |
| Colony Stimulating Factors - Pegfilgrastim Products PA Policy_Commercial | Policy |
| Colony Stimulating Factors - Pegfilgrastim Products, Rolvedon and Ryzneuta PSM for Flex, High Performance, and National Preferred Formularies | Policy |
| Colony Stimulating Factors - Rolvedon PA | Policy |
| Complement Inhibitors - Empaveli PA Policy_Commercial | Policy |
| Complement Inhibitors - Fabhalta PA_Commercial | Policy |
| Complement Inhibitors - PiaSky PA | Policy |
| Complement Inhibitors - Ultomiris PA | Policy |
| Complement Inhibitors - Veopoz PA | Policy |
| Complement Inhibitors - Voydeya PA_Commercial | Policy |
| Complement Inhibitors - Zilbrysq PA | Policy |
| Complement Inhibitors – Ultomiris Subcutaneous PA Policy | Policy |
| Complement System Disorders – WHIM Syndrome – Xolremdi PA Policy_Commercial | Policy |
| Compounded Select Topical Medications PA Policy | Policy |
| Contraceptives - Oral, Patch, and Vaginal Ring Products Step Therapy Policy | Policy |
| Coronavirus Disease - Evusheld PA | Policy |
| Corticosteroids (Intraarticular) - Zilretta PA | Policy |
| Cushing's - Recorlev PA Policy | Policy |
| Cushing's - Signifor PA Policy | Policy |
| Cushings - Mifepristone PSM | Policy |
| Cyclooxygenase - 2 Inhibitor Step Therapy Policy | Policy |
| Cystic Fibrosis - Bronchitol PA Policy_Commercial | Policy |
| Cystic Fibrosis - Pulmozyme PA Policy | Policy |
| Cystic Fibrosis (Transmembrane Conductance Regulator) - Kalydeco PA_Commercial | Policy |
| Cystic Fibrosis (Transmembrane Conductance Regulator) - Orkambi PA_Commercial | Policy |
| Cystic Fibrosis (Transmembrane Conductance Regulator) - Symdeko PA_Commercial | Policy |
| Cystic Fibrosis (Transmembrane Conductance Regulator) - Trikafta PA | Policy |
| Cystic Fibrosis Transmembrane Conductance Regulator - Alyftrek PA_Commercial | Policy |
| Dermatology - Anzupgo PA | Policy |
| Dermatology - Filsuvez PA | Policy |
| Dermatology - Gene Therapy - Vyjuvek PA_Commercial | Policy |
| Dermatology - Hyftor PA_Commercial | Policy |
| Desmopressin Products - Nocdurna PA Policy | Policy |
| Diabetes - Continuous Glucose Monitoring Systems PA Policy | Policy |
| Diabetes - Dipeptidyl Peptidase-4 Inhibitors Step Therapy | Policy |
| Diabetes - Glucagon-Like Peptide-1 Agonists (Optional) PA | Policy |
| Diabetes - Glucagon-Like Peptide-1 Agonists PA Policy | Policy |
| Diabetes - Metformin Care Value Policy | Policy |
| Diabetes - Metformin Step Therapy Policy | Policy |
| Diabetes - Sodium Glucose Co-Transporter-2 and Dipeptidyl Peptidase-4 Inhibitors Step Therapy | Policy |
| Diabetes - Sodium Glucose Co-Transporter-2 Inhibitors Step Therapy | Policy |
| Diabetes - Symlin PA Policy | Policy |
| Diabetes - Tzield PA | Policy |
| Dichlorphenamide PA Policy_Commercial | Policy |
| Dichlorphenamide PSM | Policy |
| Diuretics - Loop Products Step Therapy Policy | Policy |
| Dronabinol PA with Step Therapy Policy_Commercial | Policy |
| Dronabinol Products PA | Policy |
| Enspryng PA Policy_Commercial | Policy |
| Enzyme Replacement Therapy - Elfabrio | Policy |
| Enzyme Replacement Therapy - Lamzede PA | Policy |
| Enzyme Replacement Therapy - Strensiq PA Policy | Policy |
| Enzyme Replacement Therapy - Sucraid PA Policy_Commercial | Policy |
| Enzyme Replacement Therapy - Xenpozyme PA | Policy |
| Epinephrine Auto-Injectors Step Therapy Policy | Policy |
| Erectile Dysfunction - Tadalafil (Cialis) PA Policy | Policy |
| Erythropoiesis - Stimulating Agents Preferred Specialty Management Policy for High Performance and National Preferred Formularies | Policy |
| Erythropoiesis-Stimulating Agents - Epoetin Alfa Products PA | Policy |
| Erythropoiesis-Stimulating Agents - Epoetin Alfa Products PA Policy | Policy |
| Erythropoiesis-Stimulating Agents PSM for High Performance and National Preferred Formularies | Policy |
| Estrogen - Transdermal Step Therapy Policy | Policy |
| Ezetimibe (Zetia) Step Therapy Policy | Policy |
| Fabry Disease - Galafold PA Policy_Commercial | Policy |
| Familial Chylomicronemia Syndrome - Redemplo PA | Policy |
| Familial Chylomicronemia Syndrome - Tryngolza PA_Commercial | Policy |
| Fenofibrate Step Therapy Policy | Policy |
| Gabapentin Step Therapy Policy | Policy |
| Gastroenterology - Eohilia PA | Policy |
| Gastroenterology - Gimoti PA | Policy |
| Gaucher Disease - Substrate Reduction Therapy Agents | Policy |
| Gaucher Disease - Substrate Reduction Therapy Care Value Policy | Policy |
| Gaucher Disease - Substrate Reduction Therapy PSM Policy | Policy |
| Gaucher Disease Substrate Reduction Therapy - Cerdelga PA Policy_Commercial | Policy |
| Gaucher Disease Substrate Reduction Therapy - Miglustat PA | Policy |
| Gonadotropin-Releasing Hormone Agonist - Lupron Depot PA | Policy |
| Gonadotropin-Releasing Hormone Agonist - Synarel PA Policy_Commercial | Policy |
| Gonadotropin-Releasing Hormone Agonists - Central Precocious Puberty PA Policy | Policy |
| Gonadotropin-Releasing Hormone Agonists - Injectable Long-Acting Products (Lupron Depot-Ped and Triptodur) PA | Policy |
| Gonadotropin-Releasing Hormone Antagonists - Oriahnn PA Policy_Commercial | Policy |
| Gonadotropin-Releasing Hormone Antagonists - Orilissa PA Policy | Policy |
| Gout Medications Step Therapy Policy_Commercial | Policy |
| Growth Disorders - Growth Hormone Long-Acting Products PSM | Policy |
| Growth Disorders - Growth Hormone PA_Commercial | Policy |
| Growth Disorders - Growth Hormone Short-Acting Products PSM Policy | Policy |
| Growth Disorders - Increlex PA Policy_Commercial | Policy |
| Growth Disorders - Ngenla PA_Commercial | Policy |
| Growth Disorders - Sogroya PA | Policy |
| Growth Disorders - Voxzogo PA_Commercial | Policy |
| Hemangeol PA with Step Therapy Policy_Commercial | Policy |
| Hematology - Adzynma PA | Policy |
| Hematology - Aphexda PA | Policy |
| Hematology - Cablivi PA Policy_Commercial | Policy |